Skip to content

The psychosocial impact of haematopoietic stem cell donation on adult related donors

A multi-center, prospective, exploratory study of the psychosocial impact of donating haematopoietic stem cells on adult related donors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617000407392
Acronym
IMPECT
Enrollment
47
Registered
2017-03-20
Start date
2017-02-16
Completion date
2018-04-20
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Background: While World Marrow Donor Association Standards ensure consistency in the assessment and care of unrelated haematopoietic stem cell (HSC) donors, no such criteria exist for related HSC donors. Unlike unrelated donors, related donors are actively involved in the transplant process and witness first-hand the changes in their relative’s health. Their lived experience is thus likely to be very different from that of unrelated donors and it is important to understand and address their needs. Aim: The aim of this PhD project is to identify potential predictors of psychosocial distress and unmet needs of adult related HSC donors, to develop information resources for health professionals and develop and pilot test a psycho-educational resource for donors. PHASE I Participants are adults undergoing HSC donation for a related recipient at the RBWH and Westmead Hospital, Sydney. Donors complete 3 interviews and provide 3 samples of saliva (as a measure of stress): (1) 2 weeks pre-HSC collection; (2) within 24hrs of HSC collection and; (3) 30 days post-HSC collection. An interview with BMT Nurses will explore the nature of their role, their perceptions of the psychosocial needs of donors and their role (if any) in responding to donor distress. Hypotheses: As research into adult related donors is limited, findings from research with younger related HSC donors and adult bone marrow donors were used to make the following predictions: 1. Donor perceptions of the closeness of the relationship with the recipient will be associated with post-donation reactions such as guilt, responsibility and stress. 2. Perceived adequacy of preparation and emotional support will correlate with post-donation reactions such as concern for own health, physical pain/discomfort, guilt and responsibility. 3. Donors with poorer self-evaluated health-related quality of life will report more negative reactions throughout the process. 4. Donors of recipients who experience adverse clinical events (such as development of graft versus-host-disease) will experience increased distress and anxiety. 5. Donor reactions such as stress/physical pain will correlate with high salivary a-amylase levels throughout the process. PHASE II Key indicators that identify risk of HSC donation-related distress will be used to develop a paper-based psycho-educational resource that seeks to reduce related HSC donor distress and may be appropriate for integration within the health system. We aim to assess acceptability, feasibility and potential efficacy and inform the development of a large post-doctoral study which will be required to validate the tool.

Interventions

PHASE 1 Group 1 - adult related stem cell transplant donors Adult related stem cell transplant donors of planned allogeneic transplant recipients will complete three semi-structured interviews and provide three samples of saliva (as a measure of stress) at the following time points: (T1) Within 2 weeks before the stem cell mobilisation commences; (T2) Within 24 hours (pre- or post-donation) of the donors’ stem cell collection and; (T3) Within 2 weeks of the 30-day anniversary of the stem cell

PHASE 1 Group 1 - adult related stem cell transplant donors Adult related stem cell transplant donors of planned allogeneic transplant recipients will complete three semi-structured interviews and provide three samples of saliva (as a measure of stress) at the following time points: (T1) Within 2 weeks before the stem cell mobilisation commences; (T2) Within 24 hours (pre- or post-donation) of the donors’ stem cell collection and; (T3) Within 2 weeks of the 30-day anniversary of the stem cell collection. Group 2 - Adult related lymphocyte infusion donors Adult related lymphocyte donors of planned lymphocyte infusions recipients are included in this study to consider any potential effect granulocyte colony-stimulating factor (GCSF) may have on salivary alpha-amylase levels. Related lymphocyte donors will provide three samples of saliva at the following time points: (T1) Within 2 weeks before the lymphocyte collection; (T2) Within 24 hours (pre- or post-donation) of the donors’ lymphocyte collection and; (T3) Within 2 weeks of the 30-day anniversary of the lymphocyte collection Group 3 - Bone Marrow Transplant Nurses Bone Marrow Transplant Nurses will complete one interview towards the end of the study. The interview will explore the nature of their role, their perceptions of the psychosocial needs of donors and their role (if any) in responding to donor distress. PHASE II In response to the needs identified through interviews with adult related stem cell donors and nurses, a psycho-educational resource will be developed to improve donor efficacy and promote self-care. Adult related stem cell donors and Nurses from Phase I will be re-contacted and asked to evaluate the psychoeducational resource. A study pack including an information sheet, resource, questionnaire and reply paid envelope for returning the questionnaire will be mailed to potential participants. Consent is presumed by completion and return of the postal questionnaire in a reply paid envelope. Questionnaires will take approximately 20 minutes to complete.

Sponsors

University of Queensland
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Update Group 1: Adult related stem cell transplant donors of planned allogeneic transplant recipients. Group 2: Adult related lymphocyte donors of planned lymphocyte infusion recipients. Group 3: BMT Nurses within the RBWH and Westmead Hospital Haematology and Bone Marrow Transplant Units. 1) Ages eligible for study: 18 to 70 years 2) Able to provide informed consent

Exclusion criteria

People whose primary language is other than English Women who are pregnant and the human fetus Children and/or young people (ie. <18 years) People with a cognitive impairment, an intellectual disability or a mental illness

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 2, 2026